Comparative intravitreal Conbercept versus Ranibizumab in macular edema secondary to retinal vein occlusion: a Meta-analysis
AIM: To compare the efficacy and safety of intravitreal conbercept and ranibizumab in the treatment of macular edema secondary to retinal vein occlusion(RVO-ME)in order to provide basis for clinical guidance.<p>METHODS: The Cochrane Library, Embase, Web of Science, and CNKI, Wanfang data, and...
Main Authors: | Li Peng, Xiao-Hua Zhang, Na Lao, Qing Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2020-03-01
|
Series: | Guoji Yanke Zazhi |
Subjects: | |
Online Access: | http://ies.ijo.cn/cn_publish/2020/3/202003011.pdf |
Similar Items
-
Efficacy of first Ranibizumab intravitreal injection on macular edema caused by retinal vein occlusion
by: Hong Cao, et al.
Published: (2015-09-01) -
Efficacy and prognostic factors of Ranibizumab in the treatment of macular edema secondary to retinal vein occlusion
by: Zhi-Jun Shen, et al.
Published: (2022-10-01) -
Systematic evaluation of the efficacy of Conbercept and Ranibizumab in the treatment of macular edema secondary to retinal vein occlusion
by: Man Yu, et al.
Published: (2020-12-01) -
Intravitreal ranibizumab improves macular sensitivity in patients with central retinal vein occlusion and macula edema
by: Taro Otawa, et al.
Published: (2022-06-01) -
Comparison of intravitreal ranibizumab monotherapy vs. ranibizumab combined with dexamethasone implant for macular edema secondary to retinal vein occlusion
by: Xuemei Liang, et al.
Published: (2022-09-01)